|
|
Article: Modafinil Receives Marketing Approval In Mexico.
- Article from:
- Biotech Week
- Article date:
- February 27, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 FEB 20 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) an international biopharmaceutical company, announced that its partner, Armstrong Laboratorios de Mexico S.A.C.V., has received approval to sell and distribute modafinil in Mexico. Armstrong will market modafinil under the brand name, Modiodal. Cephalon controls worldwide rights to modafinil, marketed as PROVIGIL (modafinil) tablets [C- IV] in the United States and several other countries.
Provigil is a unique, wake-promoting agent currently approved in several countries for the treatment of excessive daytime sleepiness associated with narcolepsy. The most common side ...